Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1[Dexamethasone sodium phosphate]
(D00292)		[1] Dexamethasone[3] Dexamethasone (D00292),
Dexamethasone sodium phosphate ,
Dexamethasone phosphate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 65 💬
2Bortezomib+Dexamethasone/Bortezomib+Dexamethasone+Daratumumab/single Daratumumab
(D00292)		[3] Bortezomib,
Daratumumab,
Dexamethasone		[5] Dexamethasone (D00292),
Dexamethasone sodium phosphate ,
Bortezomib ,
Dexamethasone phosphate ,
Daratumumab 💬 		[3] CD38,
NR3C1,
PSMB5 💬 		[15] Alzheimer disease, Amyotrophic lateral sclerosis, Calcium signaling pathway, Hematopoietic cell lineage, Huntington disease, Neuroactive ligand-receptor interaction, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Salivary secretion, Spinocerebellar ataxia 💬[1] 28 💬
3Bortezomib/dexamethasone
(D00292)		[2] Bortezomib,
Dexamethasone		[4] Dexamethasone (D00292),
Dexamethasone sodium phosphate ,
Bortezomib ,
Dexamethasone phosphate 💬 		[2] NR3C1,
PSMB5 💬 		[9] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬[1] 283 💬
4Bortezomib/Dexamethasone (BD), Followed By Autologous STC & Maintenance Bortezomib/Dexamethasone
(D00292)		[2] Bortezomib,
Dexamethasone		[4] Dexamethasone (D00292),
Dexamethasone sodium phosphate ,
Bortezomib ,
Dexamethasone phosphate 💬 		[2] NR3C1,
PSMB5 💬 		[9] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬[1] 28 💬
5Bupivacaine/epinephrine/dexamethasone
(D00292)		[3] Bupivacaine,
Dexamethasone,
Epinephrine		[8] Epinephrine ,
Dexamethasone (D00292),
Dexamethasone sodium phosphate ,
Epinephrine hydrochloride ,
Bupivacaine hydrochloride ,
Epinephrine bitartrate ,
Bupivacaine ,
Dexamethasone phosphate 💬 		[16] ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C,
ADRB1,
ADRB2,
ADRB3,
NR3C1,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN8A,
SCN9A 💬 		[20] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Cadherin signaling, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Dopaminergic synapse, Gap junction, Hormone signaling, IgSF CAM signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 96 💬
6CARFILZOMIB, CYCLOPHOSPHAMIDE, DEXAMETHASONE
(D00292)		[3] Carfilzomib,
Cyclophosphamide,
Dexamethasone		[6] Cyclophosphamide ,
Dexamethasone (D00292),
Dexamethasone sodium phosphate ,
Cyclophosphamide ,
Dexamethasone phosphate ,
Carfilzomib 💬 		[2] NR3C1,
PSMB5 💬 		[9] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬[1] 16 💬
7Combination of Protein A Immunoadsorption, Rituximab, Dexamethasone plus Azathioprine
(D00292)		[3] Azathioprine,
Dexamethasone,
Rituximab		[6] Azathioprine ,
Dexamethasone (D00292),
Dexamethasone sodium phosphate ,
Rituximab ,
Azathioprine sodium ,
Dexamethasone phosphate 💬 		[2] MS4A1,
NR3C1 💬 		[2] Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬[1] 35 💬
8Control intervention (no dexamethasone)
(D00292)		[1] Dexamethasone[3] Dexamethasone (D00292),
Dexamethasone sodium phosphate ,
Dexamethasone phosphate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 46 💬
9Conventional Glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone)
(D00292)		[7] Acetate,
Cortisone,
Cortisone acetate,
Dexamethasone,
Hydrocortisone,
Prednisolone,
Prednisone		[8] Hydrocortisone ,
Dexamethasone (D00292),
Prednisolone ,
Prednisone ,
Cortisone acetate ,
Dexamethasone sodium phosphate ,
Cortisone ,
Dexamethasone phosphate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 81 💬
10Cyclophosphamide, bortezomib, and Dexamethasone (CyBorD) regimen
(D00292)		[3] Bortezomib,
Cyclophosphamide,
Dexamethasone		[6] Cyclophosphamide ,
Dexamethasone (D00292),
Dexamethasone sodium phosphate ,
Bortezomib ,
Cyclophosphamide ,
Dexamethasone phosphate 💬 		[2] NR3C1,
PSMB5 💬 		[9] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬[1] 28 💬
11Dexamethasone
(D00292)		[1] Dexamethasone[3] Dexamethasone (D00292),
Dexamethasone sodium phosphate ,
Dexamethasone phosphate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[29] 13, 14, 16, 19, 28, 35, 46, 53, 63, 64, 65, 70, 71, 74, 75, 81, 84, 90, 96, 97, 162, 222, 223, 235, 257, 283, 296, 299, 331 💬
12Dexamethasone (1 cycle)
(D00292)		[1] Dexamethasone[3] Dexamethasone (D00292),
Dexamethasone sodium phosphate ,
Dexamethasone phosphate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 63 💬
13Dexamethasone (4 cycles)
(D00292)		[1] Dexamethasone[3] Dexamethasone (D00292),
Dexamethasone sodium phosphate ,
Dexamethasone phosphate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 63 💬
14Dexamethasone (50mg 1dd6, 3 consecutive days/month)
(D00292)		[1] Dexamethasone[3] Dexamethasone (D00292),
Dexamethasone sodium phosphate ,
Dexamethasone phosphate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 35 💬
15Dexamethasone (IV)
(D00292)		[1] Dexamethasone[3] Dexamethasone (D00292),
Dexamethasone sodium phosphate ,
Dexamethasone phosphate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[2] 96, 97 💬
16Dexamethasone (or equivalent)
(D00292)		[1] Dexamethasone[3] Dexamethasone (D00292),
Dexamethasone sodium phosphate ,
Dexamethasone phosphate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 257 💬
17Dexamethasone 0,1 mg Tablets
(D00292)		[1] Dexamethasone[3] Dexamethasone (D00292),
Dexamethasone sodium phosphate ,
Dexamethasone phosphate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 81 💬
18Dexamethasone 0,5mg
(D00292)		[1] Dexamethasone[3] Dexamethasone (D00292),
Dexamethasone sodium phosphate ,
Dexamethasone phosphate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 84 💬
19Dexamethasone 0.5mg Tablet
(D00292)		[1] Dexamethasone[3] Dexamethasone (D00292),
Dexamethasone sodium phosphate ,
Dexamethasone phosphate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 81 💬
20Dexamethasone 0.5mg/5ml solution
(D00292)		[1] Dexamethasone[3] Dexamethasone (D00292),
Dexamethasone sodium phosphate ,
Dexamethasone phosphate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[2] 35, 162 💬
21Dexamethasone 0.5mg/5ml solution in Mucolox™
(D00292)		[1] Dexamethasone[3] Dexamethasone (D00292),
Dexamethasone sodium phosphate ,
Dexamethasone phosphate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[2] 35, 162 💬
22Dexamethasone 1,5 mg Tablets
(D00292)		[1] Dexamethasone[3] Dexamethasone (D00292),
Dexamethasone sodium phosphate ,
Dexamethasone phosphate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 81 💬
23Dexamethasone 2mg Tablets
(D00292)		[1] Dexamethasone[3] Dexamethasone (D00292),
Dexamethasone sodium phosphate ,
Dexamethasone phosphate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 81 💬
24Dexamethasone 4 mg JENAPHARM
(D00292)		[1] Dexamethasone[3] Dexamethasone (D00292),
Dexamethasone sodium phosphate ,
Dexamethasone phosphate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 28 💬
25Dexamethasone 4 Mg/mL Injectable Solution
(D00292)		[1] Dexamethasone[3] Dexamethasone (D00292),
Dexamethasone sodium phosphate ,
Dexamethasone phosphate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 70 💬
26Dexamethasone Abcur
(D00292)		[1] Dexamethasone[3] Dexamethasone (D00292),
Dexamethasone sodium phosphate ,
Dexamethasone phosphate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 63 💬
27DEXAMETHASONE ACETATE
(D00292)		[3] Acetate,
Dexamethasone,
Dexamethasone acetate		[5] Dexamethasone (D00292),
Dexamethasone sodium phosphate ,
Dexamethasone acetate ,
Dexamethasone 21-acetate ,
Dexamethasone phosphate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 63 💬
28Dexamethasone and Rituximab
(D00292)		[2] Dexamethasone,
Rituximab		[4] Dexamethasone (D00292),
Dexamethasone sodium phosphate ,
Rituximab ,
Dexamethasone phosphate 💬 		[2] MS4A1,
NR3C1 💬 		[2] Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬[1] 63 💬
29Dexamethasone Azathioprine Pulse therapy
(D00292)		[2] Azathioprine,
Dexamethasone		[5] Azathioprine ,
Dexamethasone (D00292),
Dexamethasone sodium phosphate ,
Azathioprine sodium ,
Dexamethasone phosphate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 35 💬
30Dexamethasone Combined with romiplostim N01
(D00292)		[2] Dexamethasone,
Romiplostim		[4] Dexamethasone (D00292),
Dexamethasone sodium phosphate ,
Dexamethasone phosphate ,
Romiplostim 💬 		[2] MPL,
NR3C1 💬 		[4] Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction 💬[1] 63 💬
31Dexamethasone Cyclophosphamide Pulse therapy
(D00292)		[2] Cyclophosphamide,
Dexamethasone		[5] Cyclophosphamide ,
Dexamethasone (D00292),
Dexamethasone sodium phosphate ,
Cyclophosphamide ,
Dexamethasone phosphate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 35 💬
32Dexamethasone given orally
(D00292)		[1] Dexamethasone[3] Dexamethasone (D00292),
Dexamethasone sodium phosphate ,
Dexamethasone phosphate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 13 💬
33Dexamethasone injection
(D00292)		[1] Dexamethasone[3] Dexamethasone (D00292),
Dexamethasone sodium phosphate ,
Dexamethasone phosphate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 90 💬
34Dexamethasone Krka
(D00292)		[1] Dexamethasone[3] Dexamethasone (D00292),
Dexamethasone sodium phosphate ,
Dexamethasone phosphate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 28 💬
35Dexamethasone monotherapy
(D00292)		[1] Dexamethasone[3] Dexamethasone (D00292),
Dexamethasone sodium phosphate ,
Dexamethasone phosphate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 63 💬
36Dexamethasone oral
(D00292)		[1] Dexamethasone[3] Dexamethasone (D00292),
Dexamethasone sodium phosphate ,
Dexamethasone phosphate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 63 💬
37Dexamethasone oral tablet 8mg (Dexamethasone Krka tablets(8mg), Warsaw, Poland).
(D00292)		[1] Dexamethasone[3] Dexamethasone (D00292),
Dexamethasone sodium phosphate ,
Dexamethasone phosphate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 235 💬
38Dexamethasone Oral, 10 mg
(D00292)		[1] Dexamethasone[3] Dexamethasone (D00292),
Dexamethasone sodium phosphate ,
Dexamethasone phosphate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 28 💬
39Dexamethasone Oral, 20 mg
(D00292)		[1] Dexamethasone[3] Dexamethasone (D00292),
Dexamethasone sodium phosphate ,
Dexamethasone phosphate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 28 💬
40Dexamethasone palmitate
(D00292)		[2] Dexamethasone,
Dexamethasone palmitate		[4] Dexamethasone (D00292),
Dexamethasone sodium phosphate ,
Dexamethasone palmitate ,
Dexamethasone phosphate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 63 💬
41Dexamethasone Parotid Irrigation
(D00292)		[1] Dexamethasone[3] Dexamethasone (D00292),
Dexamethasone sodium phosphate ,
Dexamethasone phosphate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 53 💬
42DEXAMETHASONE SODIUM PHOSPHATE
(D00292)		[1] Dexamethasone[3] Dexamethasone (D00292),
Dexamethasone sodium phosphate ,
Dexamethasone phosphate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[3] 65, 70, 96 💬
43Dexamethasone sodium phosphate (soluzione 25mg/ml)
(D00292)		[1] Dexamethasone[3] Dexamethasone (D00292),
Dexamethasone sodium phosphate ,
Dexamethasone phosphate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 65 💬
44Dexamethasone sodium phosphate 250 mg/ 10 ml
(D00292)		[1] Dexamethasone[3] Dexamethasone (D00292),
Dexamethasone sodium phosphate ,
Dexamethasone phosphate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 96 💬
45Dexamethasone sodium phosphate 250 mg/10 ml solution
(D00292)		[1] Dexamethasone[3] Dexamethasone (D00292),
Dexamethasone sodium phosphate ,
Dexamethasone phosphate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 299 💬
46DEXAMETHASONE SODIUM PHOSPHATE PH. EUR.
(D00292)		[1] Dexamethasone[3] Dexamethasone (D00292),
Dexamethasone sodium phosphate ,
Dexamethasone phosphate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 65 💬
47DEXAMETHASONE SODIUM SULFATE
(D00292)		[2] Dexamethasone,
Sodium sulfate		[5] Dexamethasone (D00292),
Dexamethasone sodium phosphate ,
Anhydous sodium sulfate ,
Sodium sulfate ,
Dexamethasone phosphate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 28 💬
48Dexamethasone soduim phosphate
(D00292)		[1] Dexamethasone[3] Dexamethasone (D00292),
Dexamethasone sodium phosphate ,
Dexamethasone phosphate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 13 💬
49Dexamethasone USP Micronized
(D00292)		[1] Dexamethasone[3] Dexamethasone (D00292),
Dexamethasone sodium phosphate ,
Dexamethasone phosphate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 63 💬
50Dexamethasone, 40 mg
(D00292)		[1] Dexamethasone[3] Dexamethasone (D00292),
Dexamethasone sodium phosphate ,
Dexamethasone phosphate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 28 💬
51Dexamethasone, procarbazine
(D00292)		[2] Dexamethasone,
Procarbazine		[5] Dexamethasone (D00292),
Procarbazine hydrochloride ,
Dexamethasone sodium phosphate ,
Dexamethasone phosphate ,
Procarbazine 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 65 💬
52Diagnostic Test: Dexamethasone suppression test
(D00292)		[1] Dexamethasone[3] Dexamethasone (D00292),
Dexamethasone sodium phosphate ,
Dexamethasone phosphate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 75 💬
53Diagnostic Test: Dexamethasone test
(D00292)		[1] Dexamethasone[3] Dexamethasone (D00292),
Dexamethasone sodium phosphate ,
Dexamethasone phosphate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 75 💬
54Eltrombopag and dexamethasone
(D00292)		[2] Dexamethasone,
Eltrombopag		[5] Dexamethasone (D00292),
Dexamethasone sodium phosphate ,
Eltrombopag olamine ,
Dexamethasone phosphate ,
Eltrombopag choline 💬 		[2] MPL,
NR3C1 💬 		[4] Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction 💬[1] 63 💬
55Epidural steroid (dexamethasone) injection
(D00292)		[1] Dexamethasone[3] Dexamethasone (D00292),
Dexamethasone sodium phosphate ,
Dexamethasone phosphate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 70 💬
56High dose dexamethasone
(D00292)		[1] Dexamethasone[3] Dexamethasone (D00292),
Dexamethasone sodium phosphate ,
Dexamethasone phosphate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 63 💬
57High dose Dexamethasone pulses
(D00292)		[1] Dexamethasone[3] Dexamethasone (D00292),
Dexamethasone sodium phosphate ,
Dexamethasone phosphate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 63 💬
58High-dose Dexamethasone
(D00292)		[1] Dexamethasone[3] Dexamethasone (D00292),
Dexamethasone sodium phosphate ,
Dexamethasone phosphate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 63 💬
59High-Dose Dexamethasone Combined
(D00292)		[1] Dexamethasone[3] Dexamethasone (D00292),
Dexamethasone sodium phosphate ,
Dexamethasone phosphate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 63 💬
60High-Dose Dexamethasone Combined with Orelabrutinib
(D00292)		[2] Dexamethasone,
Orelabrutinib		[4] Dexamethasone (D00292),
Dexamethasone sodium phosphate ,
Dexamethasone phosphate ,
Orelabrutinib 💬 		[2] BTK,
NR3C1 💬 		[8] B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Neuroactive ligand-receptor interaction, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬[1] 63 💬
61Intraarticular dexamethasone
(D00292)		[1] Dexamethasone[3] Dexamethasone (D00292),
Dexamethasone sodium phosphate ,
Dexamethasone phosphate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 46 💬
62Intravenous Dexamethasone 1 mg
(D00292)		[1] Dexamethasone[3] Dexamethasone (D00292),
Dexamethasone sodium phosphate ,
Dexamethasone phosphate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 46 💬
63Lenalidomide and dexamethasone
(D00292)		[2] Dexamethasone,
Lenalidomide		[4] Dexamethasone (D00292),
Dexamethasone sodium phosphate ,
Lenalidomide ,
Dexamethasone phosphate 💬 		[2] NR3C1,
TNF 💬 		[67] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 16 💬
64Lenalidomide+Dexamethasone
(D00292)		[2] Dexamethasone,
Lenalidomide		[4] Dexamethasone (D00292),
Dexamethasone sodium phosphate ,
Lenalidomide ,
Dexamethasone phosphate 💬 		[2] NR3C1,
TNF 💬 		[67] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 16 💬
65Lenalidomide, Dexamethasone
(D00292)		[2] Dexamethasone,
Lenalidomide		[4] Dexamethasone (D00292),
Dexamethasone sodium phosphate ,
Lenalidomide ,
Dexamethasone phosphate 💬 		[2] NR3C1,
TNF 💬 		[67] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 16 💬
66Lenalidomide, Dexamethasone and Cyclophosphamide
(D00292)		[3] Cyclophosphamide,
Dexamethasone,
Lenalidomide		[6] Cyclophosphamide ,
Dexamethasone (D00292),
Dexamethasone sodium phosphate ,
Lenalidomide ,
Cyclophosphamide ,
Dexamethasone phosphate 💬 		[2] NR3C1,
TNF 💬 		[67] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 28 💬
67Live Combined Bacillus Subtilis and Enterococcus Faecium Enteric-coated Capsules combined with Bortezomib+Dexamethasone/Bortezomib+Dexamethasone+Daratumumab/single Daratumumab
(D00292)		[5] Bacillus subtilis,
Bortezomib,
Daratumumab,
Dexamethasone,
Enterococcus faecium		[5] Dexamethasone (D00292),
Dexamethasone sodium phosphate ,
Bortezomib ,
Dexamethasone phosphate ,
Daratumumab 💬 		[3] CD38,
NR3C1,
PSMB5 💬 		[15] Alzheimer disease, Amyotrophic lateral sclerosis, Calcium signaling pathway, Hematopoietic cell lineage, Huntington disease, Neuroactive ligand-receptor interaction, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Salivary secretion, Spinocerebellar ataxia 💬[1] 28 💬
68Melphalan, thalidomide and dexamethasone
(D00292)		[3] Dexamethasone,
Melphalan,
Thalidomide		[6] Dexamethasone (D00292),
Melphalan ,
Thalidomide ,
Dexamethasone sodium phosphate ,
Dexamethasone phosphate ,
Melphalan hydrochloride 💬 		[2] NR3C1,
TNF 💬 		[67] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 28 💬
69MMF and Dexamethasone
(D00292)		[1] Dexamethasone[3] Dexamethasone (D00292),
Dexamethasone sodium phosphate ,
Dexamethasone phosphate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 222 💬
70Peri-neural Dexamethasone 1 mg
(D00292)		[1] Dexamethasone[3] Dexamethasone (D00292),
Dexamethasone sodium phosphate ,
Dexamethasone phosphate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 46 💬
71Pomalidomide and Dexamethasone
(D00292)		[2] Dexamethasone,
Pomalidomide		[4] Dexamethasone (D00292),
Dexamethasone sodium phosphate ,
Dexamethasone phosphate ,
Pomalidomide 💬 		[3] IL6,
NR3C1,
TNF 💬 		[79] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 28 💬
72Rituximab and dexamethasone
(D00292)		[2] Dexamethasone,
Rituximab		[4] Dexamethasone (D00292),
Dexamethasone sodium phosphate ,
Rituximab ,
Dexamethasone phosphate 💬 		[2] MS4A1,
NR3C1 💬 		[2] Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬[1] 63 💬
73Romiplostim N01 combined with dexamethasone
(D00292)		[2] Dexamethasone,
Romiplostim		[4] Dexamethasone (D00292),
Dexamethasone sodium phosphate ,
Dexamethasone phosphate ,
Romiplostim 💬 		[2] MPL,
NR3C1 💬 		[4] Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction 💬[1] 63 💬
74Romiplostim plus dexamethasone
(D00292)		[2] Dexamethasone,
Romiplostim		[4] Dexamethasone (D00292),
Dexamethasone sodium phosphate ,
Dexamethasone phosphate ,
Romiplostim 💬 		[2] MPL,
NR3C1 💬 		[4] Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction 💬[1] 63 💬
75SoC: cyclophosphamide, bortezomib, and Dexamethasone (CyBorD)
(D00292)		[3] Bortezomib,
Cyclophosphamide,
Dexamethasone		[6] Cyclophosphamide ,
Dexamethasone (D00292),
Dexamethasone sodium phosphate ,
Bortezomib ,
Cyclophosphamide ,
Dexamethasone phosphate 💬 		[2] NR3C1,
PSMB5 💬 		[9] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬[1] 28 💬
76Venetoclax MTD with Dexamethasone
(D00292)		[2] Dexamethasone,
Venetoclax		[4] Dexamethasone (D00292),
Dexamethasone sodium phosphate ,
Dexamethasone phosphate ,
Venetoclax 💬 		[2] BCL2,
NR3C1 💬 		[41] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Amyotrophic lateral sclerosis, Apoptosis, Apoptosis - multiple species, Autophagy - animal, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Colorectal cancer, Epstein-Barr virus infection, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, Gastric cancer, HIF-1 signaling pathway, Hedgehog signaling pathway, Hepatitis B, Herpes simplex virus 1 infection, Human immunodeficiency virus 1 infection, JAK-STAT signaling pathway, Lipid and atherosclerosis, Measles, MicroRNAs in cancer, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Neuroactive ligand-receptor interaction, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Prostate cancer, Protein processing in endoplasmic reticulum, Salmonella infection, Shigellosis, Small cell lung cancer, Sphingolipid signaling pathway, Toxoplasmosis, Tuberculosis, p53 signaling pathway 💬[1] 28 💬